Annals of Surgical Oncology

, Volume 9, Issue 3, pp 256–265 | Cite as

Predictors of locoregional recurrence among patients with early-stage breast cancer treated with breast-conserving therapy

  • Nadeem Q. Mirza
  • Georges Vlastos
  • Funda Meric
  • Thomas A. Buchholz
  • Nestor Esnaola
  • S. Eva Singletary
  • Henry M. Kuerer
  • Lisa A. Newman
  • Frederick C. Ames
  • Merrick I. Ross
  • Barry W. Feig
  • Raphael E. Pollock
  • Marsha McNeese
  • Eric Strom
  • Kelly K. Hunt
Original Articles



Our aim was to identify predictors of locoregional recurrence (LRR) in patients with early-stage breast cancer treated with breast-conserving therapy (BCT) and long-term follow-up.


From 1970 to 1994, 1153 patients with stage I to II breast cancer underwent BCT and radiotherapy at our institution. Patients with prior breast cancer or other primary malignancies were excluded. Clinical and pathologic characteristics evaluated were age, race, tumor size, stage, pathologic tumor margins, axillary nodal involvement, estrogen and progesterone receptor status, Black's nuclear grade, type of surgery, and use of adjuvant therapy.


Of 1083 patients, 54% presented with stage I disease and 46% with stage II disease. Median age was 50 years, and median follow-up was 9 years. Axillary nodes were positive in 31% of the patients who underwent axillary dissection. LRR developed in 6%, LRR followed by systemic recurrence in 5%, and systemic recurrence alone in 13%, 76% had no evidence of recurrence at last follow-up. Age, tumor size, positive lymph nodes, and not receiving chemotherapy or hormonal therapy were independent predictors of LRR. Disease-specific survival among patients with LRR was similar to that among patients with no recurrence.


Multidisciplinary treatment strategies should be used to accomplish durable locoregional control after BCT.

Key Words

Breast neoplasms Local recurrence Predictors Breast-conserving therapy Survival 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Haffty, BG, Fischer D, Beinfield M, McKhann C. Prognosis following local recurrence in the conservatively treated breast cancer patient.Int J Radiat Oncol Biol Phys 1991;21:293–8.PubMedGoogle Scholar
  2. 2.
    Treatment of early-stage of breast cancer. National Institute of Health Consensus Conference.JAMA 1991;265:391–5.Google Scholar
  3. 3.
    Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001.CA Cancer J Clin 2001;51:15–36.PubMedCrossRefGoogle Scholar
  4. 4.
    Harris JR, Hellman S.The Results of Primary Radiation Therapy for Early Breast Cancer at the Joint Center for Radiation Therapy. Philadelphia: JB Lippincott, 1983.Google Scholar
  5. 5.
    Montague ED. Conservation surgery and radiation therapy in the treatment of operable breast cancer.Cancer 1984;53:700–4.PubMedCrossRefGoogle Scholar
  6. 6.
    Danoff BF, Pajak TF, Solin LJ, Goodman RL. Excisional biopsy, axillary node dissection and definitive radiotherapy for stages I and II breast cancer.Int J Radiat Oncol Biol Phys 1985;11:479–83.PubMedGoogle Scholar
  7. 7.
    Calle R, Vilcoq JR, Zafrani B, Vielh P, Fourquet A. Local control and survival of breast cancer treated by limited surgery followed by irradiation.Int J Radiat Oncol Biol Phys 1986;12:873–8.PubMedGoogle Scholar
  8. 8.
    Veronesi U, Banfi A, Salvador B, et al. Breast conservation is the treatment of choice in small breast cancer: long-term results of a randomized trial.Eur J Cancer 1990;26:668–70.PubMedCrossRefGoogle Scholar
  9. 9.
    Sarrazin D, Le MG, Arriagada R, et al. Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer.Radiother Oncol 1989;14:177–84.PubMedCrossRefGoogle Scholar
  10. 10.
    Fisher B, Redmond C, Poisson R, et al. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer.N Engl J Med 1989;320:822–8.PubMedCrossRefGoogle Scholar
  11. 11.
    Delouche G, Bachelot F, Premont M, Kurtz JM. Conservation treatment of early breast cancer: long term results and complications.Int J Radiat Oncol Biol Phys 1987;13:29–34.PubMedGoogle Scholar
  12. 12.
    Rayte Z, Gazet JC, Ford HT, Easton DF, Coombes RC. Comparison of conservative surgery and radiotherapy with mastectomy in the treatment of early breast cancer.Eur J Surg Oncol 1990;16: 486–92.Google Scholar
  13. 13.
    Veronesi U, Luini A, Galimberti V, Zurrida S. Conservation approaches for the management of stage I/II carcinoma of the breast: Milan Cancer Institute trials.World J Surg 1994;18:70–5.PubMedCrossRefGoogle Scholar
  14. 14.
    Fisher B, Redmond C. Lumpectomy for breast cancer: an update of the NSABP experience.J Natl cancer Inst Monogr 1992;11:7–13.PubMedGoogle Scholar
  15. 15.
    Straus K, Lichter A, Lippman M, et al. Results of the National Cancer Institute early breast cancer trial.J Natl Cancer Inst Monogr 1992;11:27–32.PubMedGoogle Scholar
  16. 16.
    van Dongen JA, Bartelink H, Fentiman IS, et al. Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial.J Natl Cancer Inst Monogr 1992;11:1508.Google Scholar
  17. 17.
    Blichert-Toft M, Rose C, Andersen JA, et al. Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis.J Natl Cancer Inst Monogr 1992;11: 19–25.PubMedGoogle Scholar
  18. 18.
    Macmillan RD, Purushotham AD, George WD. Local recurrence after breast-conserving surgery for breast cancer.Br J Surg 1995; 83:149–55.CrossRefGoogle Scholar
  19. 19.
    Recht A, Connolly JL, Schnitt SJ, et al. The effect of young age on tumor recurrence in the treated breast after conservative surgery and radiotherapy.Int J Radiat Oncol Biol Phys 1987;14:3–10.Google Scholar
  20. 20.
    Kurtz JM, Jacquemir J, Amalric R, et al. Risk factors for breast recurrence in premenopausal and postmenopausal patients with ductal cancers treated by conservation therapy.Cancer 1990;65: 1867–78.PubMedCrossRefGoogle Scholar
  21. 21.
    Boyages J, Recht A, Connolly JL, et al. Early breast cancer: predictors of breast recurrence for patients treated with conservative surgery and radiation therapy.Radiother Oncol 1990;19:29–41.PubMedCrossRefGoogle Scholar
  22. 22.
    Stotter AT, McNeese MD, Ames FC, et al. Predicting the rate and extent of locoregional failure after breast conservation therapy for early breast cancer.Cancer 1989;64:2217–25.PubMedCrossRefGoogle Scholar
  23. 23.
    Katz A, Strom EA, Buchholz T, et al. Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation.J Clin Oncol 2000;18: 2817–27.PubMedGoogle Scholar
  24. 24.
    Kurtz JM, Jacquemir J, Amalric R, et al. Why are local recurrences after breast-conserving therapy more frequent in younger patients?J Clin Oncol 1990;8:591–8.PubMedGoogle Scholar
  25. 25.
    Miller A, von Fournier D, Kaufmann M, et al. Whole breast irradiation and boost irradiation in breast conserving therapy based on morphologic findings.Breast Dis 1989;2:121–30.Google Scholar
  26. 26.
    Eberlein TJ, Connolly JL, Schnitt SJ, et al. Predictors of local recurrence following conservative breast surgery and radiation therapy: the influence of tumor size.Arch Surg 1990;125:771–7.PubMedGoogle Scholar
  27. 27.
    Jacquemier J, Kurtz JM, Amalric R, et al. An assessment of extensive intraductal component as a risk factor for local recurrence after breast-conserving therapy.Br J Cancer 1990;61:873–6.PubMedGoogle Scholar
  28. 28.
    Clark RM, McCulloch PB, Levine MN, et al. Randomized clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer.J Natl Cancer Inst 1992;84:683–9.PubMedCrossRefGoogle Scholar
  29. 29.
    Hunt K, Singletary SE, Smith TL, et al. Conservation surgery and radiation: the M.D. Anderson Cancer Center experience. In: Bland KI, Copeland EM, eds.The Breast: Comprehensive Management of Benign and Malignant Disease. Philadelphia: WB Saunders, 1998:1179–82.Google Scholar
  30. 30.
    Buzdar AU, Hortobagyi GN, Kau SW.Breast Cancer Adjuvant Therapy at the M.D. Anderson Cancer Center: Results of Four Prospective Studies. Philadelphia: JB Lippincott, 1993.Google Scholar
  31. 31.
    Kaplan El, Meier P. Nonparametric estimation from incomplete observations.J Am Stat Assoc 1958;53:457–81.CrossRefGoogle Scholar
  32. 32.
    Kurtz JM, Amalric R, Brandone H, Ayme Y, Spitalier JM. Contralateral breast cancer and other second malignancies in patients treated by breast-conserving therapy with radiation.Int J Radiat Oncol Biol Phys 1988;15:277–84.PubMedCrossRefGoogle Scholar
  33. 33.
    Borger JH. The impact of surgical and pathological findings on radiotherapy of early breast cancer.Radiother Oncol 1991;22: 230–6.PubMedCrossRefGoogle Scholar
  34. 34.
    Elkhuizen PHM, van Slooten H-J, Clahsen PC, et al. High local recurrence risk after breast-conserving therapy in node-negative premenopausal breast cancer patients is greatly reduced by one course of perioperative chemotherapy: a European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group study.J Clin Oncol 2000;18:1075–60.PubMedGoogle Scholar
  35. 36.
    Voogd AC, Nielsen M, Peterse JL, et al. Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials.J Clin Oncol 2001;19:1688–97.PubMedGoogle Scholar
  36. 37.
    Kurtz JM, Spitalier JM, Amalric R, et al. Mammary recurrences in women younger than forty.Int J Radiat Oncol Biol Phys 1988;15: 271–6.PubMedCrossRefGoogle Scholar
  37. 38.
    Mate TP, Carter D, Fisher DB, et al. A clinical and histopathologic analysis of the results of conservation surgery and radiation therapy in stage I and II breast carcinoma.Cancer 1986;58:1995–2002.PubMedCrossRefGoogle Scholar
  38. 39.
    Solin LJ, Fowble B, Schultz DJ, et al. Age as a prognostic factor for patients with definitive irradiation for early stage breast cancer.Int J Radiat Oncol Biol Phys 1989;16:373–81.PubMedGoogle Scholar
  39. 40.
    Nobler MP, Venet L. Prognostic factors in patients undergoing curative irradiation for breast cancer.Int J Radiat Oncol Biol Phys 1985;11:1323–31.PubMedGoogle Scholar
  40. 41.
    Bartelink H, Borger J, van Dongen J, et al. The impact of tumor size and histology on local control after breast conserving therapy.Radiother Oncol 1988;11:297–303.PubMedCrossRefGoogle Scholar
  41. 42.
    Elkhuizen PHM, van de Vijver MJ, Hermans J, et al. Local recurrence after breast conserving treatment: high incidence in young patients and association with poor survival.Int J Radiat Oncol Biol Phys 1998;40:859–67.PubMedCrossRefGoogle Scholar
  42. 43.
    Fisher B, Anderson S. Conservative surgery for the management of invasive and noninvasive carcinoma of the breast: NSABP trials. National Surgical Adjuvant Breast and Bowel Project.World J Surg 1994;18:63–9.PubMedCrossRefGoogle Scholar
  43. 44.
    Fisher BJ, Perera FE, Cooke AL, et al. Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant systemic therapy alone: patterns of recurrence.Int J Radiat Oncol biol Phys 1997;38:541–50.PubMedCrossRefGoogle Scholar
  44. 45.
    Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status and survival in 24,740 breast cancer cases.Cancer 1988;63:181–7.CrossRefGoogle Scholar
  45. 46.
    Swenson KK, Decher L, Haselow R, et al. Prognostic factors after conservative surgery and radiation therapy for early stage breast cancer.Am J Clin Oncol 1998;21:111–6.PubMedCrossRefGoogle Scholar
  46. 47.
    Fisher B, Redmond C, Dimitrov NV, et al. A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors.N Engl J Med 1989;320:473–8.PubMedCrossRefGoogle Scholar
  47. 48.
    Fisher B, Constantino J, Redmond C, et al. A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors.N Engl J Med 1989;320:479–84.PubMedCrossRefGoogle Scholar
  48. 49.
    Fisher B, Dignam J, Wolmark N, et al. Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomized controlled trial.Lancet 1999;353: 1993–2000.PubMedCrossRefGoogle Scholar
  49. 50.
    Di Biase S, Komarnicky LT, Schwartz GF, et al. The number of positive margins influences the outcome of women treated with breast preservation for early stage breast carcinoma.Cancer 1998; 82:2212–20.CrossRefGoogle Scholar
  50. 51.
    Smitt MC, Nowels KW, Zdeblick MJ, et al. The importance of the lumpectomy surgical margin status in long term results of breast conservation.Cancer 1995;76:259–67.PubMedCrossRefGoogle Scholar
  51. 52.
    Schmitt SJ, Abner A, Gelman R, et al. The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy.Cancer 1994;74:1746–51.CrossRefGoogle Scholar
  52. 53.
    Voogd AC, Peterse JL, Crommelin MA, et al. Histological determinants for different types of local recurrence after breast-conserving therapy of invasive breast cancer.Eur J Cancer 1999;35:1828–37.PubMedCrossRefGoogle Scholar
  53. 54.
    Veronesi U, Marubini E, Del Vecchio M, et al. Local recurrences and distant metastases after breast-conserving treatments: partly independent events.J Natl Cancer Inst 1995;87:19–27.PubMedCrossRefGoogle Scholar
  54. 55.
    Kemperman H, Borger J, Hart A, et al. Prognostic factors for survival after breast conserving therapy for stage I and II breast cancer. The role of local recurrence.Eur J Cancer 1995;31A: 690–8.PubMedCrossRefGoogle Scholar
  55. 56.
    Chauvet B, Reynaud-Bougnoux A, Calais G, et al. Prognostic significance of breast relapse after conservative treatment in node-negative early breast cancer.Int J Radiat Oncol Biol Phys 1990; 19:1125–30.PubMedGoogle Scholar
  56. 57.
    Whelan T, Clark R, Roberts R, et al. Ipsilateral breast tumor recurrence post lumpectomy is predictive of subsequent mortality: results from a randomized trial.Int J Radiat Oncol Biol Phys 1994;30:11–6.PubMedGoogle Scholar

Copyright information

© The Society of Surgical Oncology, Inc 2002

Authors and Affiliations

  • Nadeem Q. Mirza
    • 1
  • Georges Vlastos
    • 1
  • Funda Meric
    • 1
  • Thomas A. Buchholz
    • 1
  • Nestor Esnaola
    • 1
  • S. Eva Singletary
    • 1
  • Henry M. Kuerer
    • 1
  • Lisa A. Newman
    • 1
  • Frederick C. Ames
    • 1
  • Merrick I. Ross
    • 1
  • Barry W. Feig
    • 1
  • Raphael E. Pollock
    • 1
  • Marsha McNeese
    • 1
  • Eric Strom
    • 2
  • Kelly K. Hunt
    • 1
  1. 1.Department of Surgical OncologyThe University of Texas M. D. Anderson Cancer CenterHouston
  2. 2.Department of Radiation OncologyThe University of Texas M. D. Anderson Cancer CenterHouston

Personalised recommendations